
[ Wed, Sep 25th 2019 ]: WOPRAI
[ Wed, Sep 25th 2019 ]: WOPRAI
[ Wed, Sep 25th 2019 ]: WOPRAI
[ Wed, Sep 25th 2019 ]: WOPRAI
[ Wed, Sep 25th 2019 ]: WOPRAI
[ Wed, Sep 25th 2019 ]: WOPRAI
[ Wed, Sep 25th 2019 ]: WOPRAI
[ Wed, Sep 25th 2019 ]: WOPRAI
[ Wed, Sep 25th 2019 ]: WOPRAI
[ Wed, Sep 25th 2019 ]: WOPRAI

[ Tue, Sep 24th 2019 ]: WOPRAI
[ Tue, Sep 24th 2019 ]: WOPRAI
[ Tue, Sep 24th 2019 ]: WOPRAI
[ Tue, Sep 24th 2019 ]: WOPRAI
[ Tue, Sep 24th 2019 ]: WOPRAI
[ Tue, Sep 24th 2019 ]: WOPRAI
[ Tue, Sep 24th 2019 ]: WOPRAI
[ Tue, Sep 24th 2019 ]: WOPRAI
[ Tue, Sep 24th 2019 ]: WOPRAI
[ Tue, Sep 24th 2019 ]: WOPRAI
[ Tue, Sep 24th 2019 ]: WOPRAI
[ Tue, Sep 24th 2019 ]: WOPRAI

[ Mon, Sep 23rd 2019 ]: WOPRAI
[ Mon, Sep 23rd 2019 ]: WOPRAI
[ Mon, Sep 23rd 2019 ]: WOPRAI
[ Mon, Sep 23rd 2019 ]: WOPRAI
[ Mon, Sep 23rd 2019 ]: WOPRAI
[ Mon, Sep 23rd 2019 ]: WOPRAI
[ Mon, Sep 23rd 2019 ]: WOPRAI
[ Mon, Sep 23rd 2019 ]: WOPRAI
[ Mon, Sep 23rd 2019 ]: WOPRAI
[ Mon, Sep 23rd 2019 ]: WOPRAI
[ Mon, Sep 23rd 2019 ]: WOPRAI

[ Fri, Sep 20th 2019 ]: WOPRAI
[ Fri, Sep 20th 2019 ]: WOPRAI
[ Fri, Sep 20th 2019 ]: WOPRAI
[ Fri, Sep 20th 2019 ]: WOPRAI
[ Fri, Sep 20th 2019 ]: WOPRAI
[ Fri, Sep 20th 2019 ]: WOPRAI
[ Fri, Sep 20th 2019 ]: WOPRAI
[ Fri, Sep 20th 2019 ]: WOPRAI
[ Fri, Sep 20th 2019 ]: WOPRAI
[ Fri, Sep 20th 2019 ]: WOPRAI
[ Fri, Sep 20th 2019 ]: WOPRAI

[ Thu, Sep 19th 2019 ]: WOPRAI
[ Thu, Sep 19th 2019 ]: WOPRAI
[ Thu, Sep 19th 2019 ]: WOPRAI
[ Thu, Sep 19th 2019 ]: WOPRAI
Charles Duncan Maintained (ACAD) at Buy with Increased Target to $56 on, Sep 23rd, 2019


🞛 This publication is a summary or evaluation of another publication
Charles Duncan of Cantor Fitzgerald, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $49 to $56 on, Sep 23rd, 2019.
Charles has made no other calls on ACAD in the last 4 months.
There are 5 other peers that have a rating on ACAD. Out of the 5 peers that are also analyzing ACAD, 1 agrees with Charles's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $28 on, Tuesday, September 3rd, 2019
These are the ratings of the 4 analyists that currently disagree with Charles
- Marc Goodman of "SVB Leerink" Upgraded from Hold to Buy and Increased Target to $50 on, Friday, September 13th, 2019
- Sumant Kulkarni of "Canaccord Genuity" Upgraded from Hold to Strong Buy on, Tuesday, September 10th, 2019
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $60 on, Monday, September 9th, 2019
- Danielle Brill of "Raymond James" Reiterated at Strong Buy with Increased Target to $43 on, Friday, May 31st, 2019
Similar Stocks and Investing Publications
[ Fri, Sep 13th 2019 ]: WOPRAI
[ Tue, Sep 10th 2019 ]: WOPRAI
[ Mon, Sep 09th 2019 ]: WOPRAI
[ Tue, Sep 03rd 2019 ]: WOPRAI
[ Mon, Jul 22nd 2019 ]: WOPRAI
[ Thu, Jul 18th 2019 ]: WOPRAI
[ Wed, May 08th 2019 ]: WOPRAI
[ Mon, May 06th 2019 ]: WOPRAI
[ Thu, Jun 28th 2018 ]: WOPRAI
[ Tue, Jun 26th 2018 ]: WOPRAI
[ Thu, Jun 21st 2018 ]: WOPRAI
[ Fri, Jun 15th 2018 ]: WOPRAI